Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CytRx initiates Phase 1b trial with combination Aldoxorubicin, Doxorubicin
The Fly on the Wall
Wednesday, July 25, 2012 - 9:46am
tags:
CytRx, aldoxorubicin, doxorubicin, solid tumors
Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healthcare Mega-Trends In The Medium Term
Seeking Alpha
Wednesday, July 25, 2012 - 9:38am
tags:
obesity, heart disease, diabetes, Amarin, MannKind, Arena Pharmaceuticals
IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
Yahoo
Wednesday, July 25, 2012 - 9:37am
tags:
IDX719, fast track, FDA, Chronic Hepatitis C, hepatitis C, Indenix
Spectrum Pharma: Fusilev Drug Sales Smash Record in June
TheStreet.com
Wednesday, July 25, 2012 - 9:35am
tags:
Fusilev, Spectrum Pharmaceuticals, colon cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
Wednesday, July 25, 2012 - 9:33am
tags:
EntreMed, triple-negative breast cancer, breast cancer, ENMD-2076
Regeneron boosts Eylea sales forecast - again
Reuters
Wednesday, July 25, 2012 - 9:31am
tags:
Eylea, Regeneron
Gilead HIV drug as good as Merck's Isentress: study
Reuters
Wednesday, July 25, 2012 - 9:30am
tags:
Gilead, HIV, Merck, Isentress, elvitegravir, Quad
A.P. Pharma to Raise $53.6 Million in Common Stock Offering
Yahoo
Wednesday, July 25, 2012 - 9:28am
tags:
AP Pharma, stock offering
[video] What's in Eli Lilly's Pharma Pipeline?
CNBC
Wednesday, July 25, 2012 - 9:26am
tags:
Eli Lilly
Earnings Preview: Merck & Co.
Yahoo/AP
Wednesday, July 25, 2012 - 9:25am
tags:
Merck, earnings
GlaxoSmithKline announces priority review for Promacta SNDA
The Fly on the Wall
Wednesday, July 25, 2012 - 9:24am
tags:
Promacta, GSK
Investing in the Companies that will Beat HIV
Motley Fool
Wednesday, July 25, 2012 - 9:22am
tags:
HIV, Gilead, JNJ, Merck, Bristol-Myers Squibb
Bristol-Myers Second-Quarter Profit Falls On Plavix Sales Drop
Bloomberg
Wednesday, July 25, 2012 - 9:08am
tags:
earnings, Bristol-Myers Squibb
Lilly Profit Beats Analyst Estimates As Cymbalta Sales Rise
Bloomberg
Wednesday, July 25, 2012 - 9:07am
tags:
earnings, Eli Lilly
10 Reasons Why Biotech Needs Big Data
Fierce Biotech IT
Tuesday, July 24, 2012 - 11:43pm
tags:
biotech, bioinformatics
Novavax pushes back additional testing of flu vaccine to 2013
Yahoo/AP
Tuesday, July 24, 2012 - 11:36pm
tags:
Flu, vaccines, Novavax
Impairment charge hits Illumina 2Q profit
Yahoo/AP
Tuesday, July 24, 2012 - 11:34pm
tags:
earnings, Illumina
Hopes dim for Alzheimer's trials after Pfizer failure
Reuters
Tuesday, July 24, 2012 - 11:32pm
tags:
Pfizer, Alzheimer's disease, Elan, JNJ, bapineuzumab
Questcor's Q2 Earnings Beat Expectations
Investors.com
Tuesday, July 24, 2012 - 11:30pm
tags:
earnings, Questcor
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Seeking Alpha
Tuesday, July 24, 2012 - 11:21pm
tags:
Zelboraf, Yervoy, melanoma, GSK, Bristol-Myers Squibb, Roche

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.